Clinical trials recruiting in Bodelwyddan, United Kingdom

Phase breakdown

Conditions recruiting in Bodelwyddan, United Kingdom

Recruiting trials in Bodelwyddan, United Kingdom

• Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
  NCT06745908 · Phase: Phase 3 · Ages: 18 Years to 90 Years · Sex: All (male and female)
• Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma
  NCT05655078 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
  NCT05093231 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
  NCT04204915 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Bodelwyddan, United Kingdom?

4 recruiting trials have at least one study site in Bodelwyddan, United Kingdom.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.